Literature DB >> 17112687

Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan.

S P Chen1, T M Ellis, M C Lee, I C Cheng, P C Yang, Y L Lin, M H Jong, I D Robertson, J R Edwards.   

Abstract

Three commercialized ELISA kits for the detection of antibodies to the non-structural proteins (NSPs) of FMD virus were compared, using sera from uninfected, vaccinated, challenged and naturally infected pigs. The kinetics of the antibody response to NSPs was compared on sequential serum samples in swine from challenge studies and outbreaks. The results showed that ELISA A (UBI) and ELISA B (CEDI) had better sensitivity than that of the 3ABC recombinant protein-based ELISA C (Chekit). The peak for detection of antibodies to NSPs in ELISA C was significantly delayed in sera from natural infection and challenged swine as compared to the ELISA A and B. The sensitivity of the three ELISAs gradually declined during the 6-month post-infection as antibodies to NSP decline. ELISA kits A and B detected NSP antibody in 50% of challenged pigs by the 9-10th-day and 7-8th-day post-challenge, respectively. ELISA B and C had better specificity than ELISA A on sequential serum samples obtained from swine immunized with a type O FMD vaccine commercially available in Taiwan. Antibody to NSPs before vaccination was not detected in swine not exposed to FMD virus, however, antibody to NSPs was found in sera of some pigs after vaccination. All assays had significantly lower specificity when testing sera from repeatedly vaccinated sows and finishers in 1997 that were tested after the 1997 FMD outbreak. However, when testing sera from repeatedly vaccinated sows or finishers in 2003-2004, the specificity for ELISAs A, B and C were significantly better than those in 1997. This effect was less marked for ELISA A. The ELISA B was the best test in terms of the highest sensitivity and specificity and the lowest reactivity with residual NSP in vaccinates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112687     DOI: 10.1016/j.vetmic.2006.09.013

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  5 in total

1.  Serosurveillance of foot and mouth disease in Karnataka state, India: a 3 years study.

Authors:  Raveendra Hegde; Srikanth Kowalli; K Nagaraja; N K Dharanesha; C M Seema; Tanveer Ahmed Khan; G V Nagaraj; K Srikala; K J Sudharshana; D Nagaraju; Shesha Rao; P Giridhara; S M Byregowda
Journal:  Virusdisease       Date:  2016-08-26

2.  Estimation of the Infection Window for the 2010/2011 Korean Foot-and-Mouth Disease Outbreak.

Authors:  Hachung Yoon; Soon-Seek Yoon; Han Kim; Youn-Ju Kim; Byounghan Kim; Sung-Hwan Wee
Journal:  Osong Public Health Res Perspect       Date:  2013-05-15

3.  Further evaluation of an ELISA kit for detection of antibodies to a nonstructural protein of foot-and-mouth disease virus.

Authors:  Katsuhiko Fukai; Tatsuya Nishi; Kazuki Morioka; Manabu Yamada; Kazuo Yoshida; Rie Kitano; Reiko Yamazoe; Toru Kanno
Journal:  J Vet Med Sci       Date:  2015-10-25       Impact factor: 1.267

4.  The Development and Validation of a Novel Nanobody-Based Competitive ELISA for the Detection of Foot and Mouth Disease 3ABC Antibodies in Cattle.

Authors:  Sigal Gelkop; Ariel Sobarzo; Polina Brangel; Cécile Vincke; Ema Romão; Shlomit Fedida-Metula; Nick Strom; Irene Ataliba; Frank Norbet Mwiine; Sylvester Ochwo; Lauro Velazquez-Salinas; Rachel A McKendry; Serge Muyldermans; Julius Julian Lutwama; Elizabeth Rieder; Victoria Yavelsky; Leslie Lobel
Journal:  Front Vet Sci       Date:  2018-10-12

5.  Inter-laboratory comparison of 2 ELISA kits used for foot-and-mouth disease virus nonstructural protein serology.

Authors:  Clare F J Browning; Antonello Di Nardo; Lissie Henry; Tim Pollard; Lynne Hendry; Aurore Romey; Anthony Relmy; Phaedra Eble; Emiliana Brocchi; Santina Grazioli; Donald P King; Anna B Ludi
Journal:  J Vet Diagn Invest       Date:  2020-10-07       Impact factor: 1.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.